Total Payments
$1,327
2024 Payments
$192.39
Companies
19
Transactions
73
Medicare Patients
2,111
Medicare Billing
$190,244
Payment Breakdown by Category
Food & Beverage$1,327 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,327 | 73 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $269.99 | 16 | $0 (2024) |
| Novo Nordisk Inc | $245.42 | 13 | $0 (2024) |
| PFIZER INC. | $196.30 | 10 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $169.11 | 4 | $0 (2019) |
| Lilly USA, LLC | $96.68 | 7 | $0 (2020) |
| ABBVIE INC. | $68.28 | 5 | $0 (2024) |
| Amgen Inc. | $36.48 | 2 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $32.08 | 2 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $32.07 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.02 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $192.39 | 9 | AstraZeneca Pharmaceuticals LP ($84.75) |
| 2022 | $23.52 | 1 | Phadia US Inc. ($23.52) |
| 2020 | $74.38 | 5 | AstraZeneca Pharmaceuticals LP ($17.37) |
| 2019 | $267.71 | 16 | AstraZeneca Pharmaceuticals LP ($84.92) |
| 2018 | $427.28 | 21 | PFIZER INC. ($155.30) |
| 2017 | $341.53 | 21 | Lilly USA, LLC ($80.24) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Obesity | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: Gastroenterology | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Obesity | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Obesity | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Respiratory | ||||||
| 04/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2022 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $23.52 | General |
| Category: Allergy/Immunology | ||||||
| 10/15/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/03/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Diabetes | ||||||
| 02/25/2020 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: IMMUNOLOGY | ||||||
| 02/11/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/07/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiovascular | ||||||
| 12/04/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/19/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Respiratory | ||||||
| 11/05/2019 | Novo Nordisk Inc | Ozempic (Drug), Tresiba | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Diabetes | ||||||
| 11/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: DIABETES | ||||||
| 10/22/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.95 | General |
| Category: Cardiovascular | ||||||
| 10/08/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Central Nervous System (CNS) | ||||||
| 08/20/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Endocrinology | ||||||
| 07/23/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 558 | 985 | $212,552 | $53,727 |
| 2022 | 4 | 444 | 863 | $103,577 | $46,992 |
| 2021 | 3 | 437 | 901 | $105,820 | $47,736 |
| 2020 | 8 | 672 | 964 | $110,091 | $41,789 |
Total Patients
2,111
Total Services
3,713
Medicare Billing
$190,244
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 322 | 719 | $158,899 | $37,868 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 100 | $31,200 | $7,734 | 24.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 28 | 28 | $11,424 | $4,332 | 37.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 21 | 21 | $2,415 | $1,511 | 62.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,549 | $1,003 | 28.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $2,121 | $606.27 | 28.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 62 | 66 | $1,584 | $554.40 | 35.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $1,360 | $118.45 | 8.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 349 | 761 | $86,754 | $39,833 | 45.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 71 | $12,496 | $5,785 | 46.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 20 | 20 | $3,480 | $1,267 | 36.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $847.00 | $106.68 | 12.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 356 | 803 | $91,542 | $41,964 | 45.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 68 | $11,968 | $5,493 | 45.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 28 | 30 | $2,310 | $278.50 | 12.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 342 | 604 | $68,856 | $24,878 | 36.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 64 | 78 | $13,728 | $4,963 | 36.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 84 | 96 | $12,072 | $4,949 | 41.0% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 61 | 61 | $3,721 | $3,683 | 99.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 71 | 75 | $7,922 | $2,122 | 26.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $2,088 | $677.11 | 32.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 26 | 26 | $780.00 | $413.66 | 53.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 12 | 12 | $924.00 | $102.84 | 11.1% |
About Dr. Charles Shiver, M.D
Dr. Charles Shiver, M.D is a Internal Medicine healthcare provider based in Milledgeville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376574905.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Shiver, M.D has received a total of $1,327 in payments from pharmaceutical and medical device companies, with $192.39 received in 2024. These payments were reported across 73 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,327).
As a Medicare-enrolled provider, Shiver has provided services to 2,111 Medicare beneficiaries, totaling 3,713 services with total Medicare billing of $190,244. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Milledgeville, GA
- Active Since 07/05/2006
- Last Updated 07/23/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376574905
Products in Payments
- ELIQUIS (Drug) $277.85
- FARXIGA (Drug) $100.29
- SYMBICORT (Drug) $77.38
- CHANTIX (Drug) $69.21
- Wegovy (Drug) $69.02
- AIRSUPRA (Drug) $63.83
- Victoza (Drug) $61.46
- Synthroid (Drug) $41.64
- Ozempic (Drug) $41.60
- TRADJENTA (Drug) $40.58
- TRULICITY (Drug) $38.17
- Tresiba (Drug) $37.99
- INVOKANA (Drug) $32.08
- XIFAXAN (Drug) $24.65
- ImmunoCAP (Device) $23.52
- JANUVIA (Drug) $22.94
- EVENITY (Biological) $20.15
- SOLIQUA 100/33 (Drug) $20.04
- Levemir (Drug) $19.89
- LYRICA (Drug) $18.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Milledgeville
Dr. Saqib Nazir, M.d, M.D
Internal Medicine — Payments: $13,728
Internal Medicine $13,728
Turkessa Walker, Md, MD
Internal Medicine — Payments: $6,766
Internal Medicine $6,766
Dr. Patrice Boddie, M.d, M.D
Internal Medicine — Payments: $1,895
Internal Medicine $1,895
Dragos Filimon, M.d, M.D
Internal Medicine — Payments: $1,533
Internal Medicine $1,533
Dr. Catherine Roberts, M.d, M.D
Internal Medicine — Payments: $1,454
Internal Medicine $1,454
Dr. Willis Roberts, M.d, M.D
Internal Medicine — Payments: $1,334
Internal Medicine $1,334